Insulin Delivery Devices - Share, Trends, Size Analysis to 2020

  • View
    188

  • Download
    0

Embed Size (px)

Transcript

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    Persistence Market Research

    Insulin Delivery Devices market will risefrom US$9,391.1 mn in 2014 to US$14,093.3mn by 2020 - Persistence Market Research

    Persistence Market Research 1

    http://www.persistencemarketresearch.com/

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    Persistence Market Research Released New Market Report Global Market Study on Insulin Delivery

    Devices: Asia to Witness Highest Growth by 2020, Persistence Market Research states that the

    market for insulin delivery devices is anticipated to expand at a healthy CAGR of 7.0% from 2014 to 2020.

    If this holds true, the value of the global market will rise from US$9,391.1 mn in 2014 to US$14,093.3 mn

    by 2020.

    Request Customize Full TOC: http://www.persistencemarketresearch.com/toc/2823

    Even with the increasing number of factors fueling the insulin delivery devices market, high cost of insulin

    analog and complications and risks associated with the delivery of insulin are anticipated to impede the

    growth of the global market. However, trends such as development of home infusion therapy and artificial

    pancreas are gaining popularity, which is sure to boost the insulin delivery devices market in the coming

    years.

    The insulin delivery devices market is segmented on the basis of device into insulin pens, insulin jet

    injectors, insulin syringes, and insulin pumps.

    Request Sample Report: http://www.persistencemarketresearch.com/samples/2823

    Different regional markets for insulin delivery devices are driven by various factors and the research

    report offers an in-depth analysis of the forces that govern the growth of each regional segment. The five

    regions covered in the global insulin delivery devices market are North America, Latin America, Asia,

    Europe, and Rest of the World.

    North America accounts for the largest share of the overall insulin delivery devices market and is

    anticipated to retain its lead throughout the forecast period. The growth in this region can be attributed to

    rise in geriatric population, alarming prevalence of diabetes, and surging number of obese and overweight

    population. The Latin America insulin delivery devices market is fueled by the establishment of several

    manufacturing and research facilities in the region.

    Persistence Market Research 2

    http://www.persistencemarketresearch.com/toc/2823http://www.persistencemarketresearch.com/market-research/insulin-delivery-device-market.asphttp://www.persistencemarketresearch.com/samples/2823http://www.persistencemarketresearch.com/

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    Asia, identified as having immense potential for future growth, is a market that is gaining prominence

    when it comes to insulin delivery devices. This development can be attributed to growing awareness

    about diabetes and the various treatment options, rise in aging population, support from government in

    the form of healthcare initiatives, and increasing prevalence of diabetes.

    Browse Full Report: http://www.persistencemarketresearch.com/market-research/insulin-delivery-

    device-market.asp

    The Europe insulin delivery devices market is driven by factors similar to those fueling the North America

    market: increase in aging population, technological advances in the delivery of insulin, growing

    prevalence of diabetes, and rising awareness among the patient population regarding treatment of

    diabetes.

    The most prominent players competing in the global insulin delivery devices market include Animas

    Corporation, B. Braun Melsungen AG, Insulet Corporation, Novo Nordisk A/S, Medtronic, Inc., Becton,

    Dickinson and Company, Sanofi, Abbott Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd.,

    and Ypsomed Holding AG. These players are profiled in the research report based on factors such as

    company overview, products and services, recent developments, and financial performance.

    Market History:

    Diabetes is a disease characterized by high blood sugar levels. It is caused by the improper functioning of

    the pancreas that secretes insulin. Insulin is a hormone that maintains blood sugar levels in the body and

    helps in the proper functioning of all cellular and physiological activities. Insulin delivery devices, such as

    insulin pens, pumps, syringes, and jet injectors, play a vital role in maintaining insulin levels in the body.

    Globally, insulin delivery devices market is growing rapidly due to increasing prevalence of diabetes and

    rising obese endemic. Additionally, advanced features of insulin delivery devices and rising awareness

    among people about diabetes care are also supporting in growth of the global insulin delivery devices

    market. The global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is

    expected to grow at a CAGR of 7% from 2014 to 2020, to reach USD 14,093.3 million by 2020.

    Persistence Market Research 3

    http://www.persistencemarketresearch.com/market-research/insulin-delivery-device-market.asphttp://www.persistencemarketresearch.com/market-research/insulin-delivery-device-market.asp

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    North America has the largest market share, followed by Europe and Asia, in the global insulin delivery

    devices market.

    The global insulin delivery devices market was valued at 7,300.0 million in 2010 and it expanded to USD

    8,793.2 million in 2013.

    Table of Content

    Chapter 1 Preface1.1 Report Description1.2 Report Methodology1.3 Assumptions

    Chapter 2 Market Synopsis

    Chapter 3 Porters Five Forces Analysis3.1 Bargaining Power of Suppliers3.2 Bargaining Power of Buyers

    Persistence Market Research 4

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    3.3 Threat of New Entrants3.4 Threat of Substitutes3.5 Intensity of Rivalry

    Chapter 4 Industry Overview4.1 Market Definition4.2 Market Drivers 4.2.1 Increasing prevalence of diabetes enhance the market growth 4.2.2 Globally rising obesity is increasing the prevalence of diabetes 4.2.3 Advanced features of insulin delivery devices attract end users 4.2.4 Rising awareness among people about diabetes care4.3 Impact Analysis of Market Drivers4.4 Market Restraints 4.4.1 Risk and complications associated with delivery of insulin 4.4.2 High cost of insulin analog impedes the market growth4.5 Impact Analysis of Market Restraints4.6 Market Trends 4.6.1 Artificial pancreas is gaining popularity in the insulin delivery devices market 4.6.2 Home infusion therapy is gaining importance in treatment of diabetes

    Chapter 5 Global Market Size and Forecast

    Chapter 6 Market Size and Forecast by Device6.1 Insulin Syringes6.2 Insulin Pens6.3 Insulin Pumps6.4 Insulin Jet Injectors

    Chapter 7 Market Size and Forecast by Geography7.1 North America 7.1.1 Scenario in the U.S. 7.1.2 Scenario in Canada7.2 Europe 7.2.1 Scenario in Germany 7.2.2 Scenario in France

    Persistence Market Research 5

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    7.2.3 Scenario in the U.K. 7.2.4 Scenario in Italy 7.2.5 Scenario in Spain7.3 Asia 7.3.1 Scenario in Japan 7.3.2 Scenario in China 7.3.3 Scenario in India7.4 Latin America 7.4.1 Scenario in Brazil

    Chapter 8 Competitive Scenario8.1 Market Share Analysis8.2 Competitive Benchmarking

    Chapter 9 Company Profiles9.1 Abbott Laboratories 9.1.1 Company Overview 9.1.2 Products and Services 9.1.3 Financial Performance 9.1.4 Recent Developments 9.2 Novo Nordisk A/S 9.2.1 Company Overview 9.2.2 Products and Services 9.2.3 Financial Performance 9.2.4 Recent Developments 9.3 Eli Lilly and Company 9.3.1 Company Overview 9.3.2 Products and Services 9.3.3 Financial Performance 9.3.4 Recent Developments9.4 Medtronic, Inc. 9.4.1 Company Overview 9.4.2 Products and Services 9.4.3 Financial Performance 9.4.4 Recent Developments

    Persistence Market Research 6

  • Insulin Delivery Devices Market driven by: Increasing

    prevalence of diabetes and obesity and others

    9.5 Sanofi 9.5.1 Company Overview 9.5.2 Products and Services 9.5.3 Financial Performance 9.5.4 Recent Developments9.6 Becton, Dickinson and Company 9.6.1 Company Overview 9.6.2 Products and Services 9.6.3 Financial Performance 9.6.4 Recent Developments 9.7 F. Hoffmann-La Roche, Ltd. 9.7.1 Company Overview 9.7.2 Products and Services 9.7.3 Financial Performance 9.7.4 Recent Developments9.8 Insulet Corporation 9.8.1 Company Overview 9.8.2 Products and Services 9.8.3 Financial Performance 9.8.4 Recent Developments 9.9 Ypsomed Holding AG 9.9.1 Company Overview 9.9.2 Products and Services 9.9.3 Financial Performance 9.9.4 Recent Developments9.10 Animas Corporation 9.10.1 Company Overview 9.10.2 Products and Services 9.10.3 Financial Performance 9.10.4 Recent Developments9.11 B. Braun Melsungen AG 9.11.1 Company Overview 9.11.2 Products and Services 9.11.3 Financial Performance 9.11.4 Recent Developments

    Persi